Bioxcel Therapeutics shares owned by Citigroup
Quarter-by-quarter ownership of Bioxcel Therapeutics (BTAI) shares owned by Citigroup
from 13F filings
Historical chart of Citigroup investment in Bioxcel Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Bioxcel Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Bioxcel Therapeutics by Citigroup
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $8.4k | 2.9k | 2.92 |
| 2023-09-30 | $62k | 24k | 2.53 |
| 2023-03-31 | $2.2M | 119k | 18.66 |
| 2022-12-31 | $13k | 619 | 21.48 |
| 2022-09-30 | $9.0k | 774 | 11.63 |
| 2021-12-31 | $1.6M | 78k | 20.33 |
| 2021-03-31 | $3.8M | 87k | 43.16 |
| 2020-12-31 | $133k | 2.9k | 46.23 |
| 2020-09-30 | $65k | 1.5k | 43.48 |
| 2020-06-30 | $857k | 16k | 53.00 |
| 2020-03-31 | $46k | 2.1k | 22.18 |
| 2019-12-31 | $20k | 1.4k | 14.38 |
| 2019-09-30 | $2.0k | 298 | 6.76 |
| 2019-06-30 | $18k | 1.7k | 10.70 |
| 2019-03-31 | $16k | 1.6k | 9.96 |